P1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT-OF-CARE ANTI CD19 CAR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000847300.61295.fe |
| _version_ | 1797287875009576960 |
|---|---|
| author | S. Fried M. J. Besser E. Shkury R. Yerushalmi N. Shem-Tov I. Danylesko E. Jacoby O. Itzhaki R. Shouval M. Kedmi A. Shimoni A. Nagler A. Avigdor |
| author_facet | S. Fried M. J. Besser E. Shkury R. Yerushalmi N. Shem-Tov I. Danylesko E. Jacoby O. Itzhaki R. Shouval M. Kedmi A. Shimoni A. Nagler A. Avigdor |
| author_sort | S. Fried |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:41:08Z |
| format | Article |
| id | doaj.art-0776b78db8784e208436f797e6145205 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:41:08Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-0776b78db8784e208436f797e61452052024-03-02T03:51:50ZengWileyHemaSphere2572-92412022-06-01699899910.1097/01.HS9.0000847300.61295.fe202206003-00998P1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT-OF-CARE ANTI CD19 CAR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMAS. Fried0M. J. Besser1E. Shkury2R. Yerushalmi3N. Shem-Tov4I. Danylesko5E. Jacoby6O. Itzhaki7R. Shouval8M. Kedmi9A. Shimoni10A. Nagler11A. Avigdor121 Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer3 Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, Tel-Aviv1 Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer1 Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer1 Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer1 Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer2 Sackler School of Medicine4 Ella Lemelbaum Institute for Immuno Oncology1 Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer1 Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer1 Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer1 Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer1 Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomerhttp://journals.lww.com/10.1097/01.HS9.0000847300.61295.fe |
| spellingShingle | S. Fried M. J. Besser E. Shkury R. Yerushalmi N. Shem-Tov I. Danylesko E. Jacoby O. Itzhaki R. Shouval M. Kedmi A. Shimoni A. Nagler A. Avigdor P1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT-OF-CARE ANTI CD19 CAR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA HemaSphere |
| title | P1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT-OF-CARE ANTI CD19 CAR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA |
| title_full | P1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT-OF-CARE ANTI CD19 CAR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA |
| title_fullStr | P1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT-OF-CARE ANTI CD19 CAR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA |
| title_full_unstemmed | P1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT-OF-CARE ANTI CD19 CAR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA |
| title_short | P1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT-OF-CARE ANTI CD19 CAR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA |
| title_sort | p1108 high complete response rate following point of care anti cd19 car t cell therapy in patients with relapsed refractory follicular lymphoma |
| url | http://journals.lww.com/10.1097/01.HS9.0000847300.61295.fe |
| work_keys_str_mv | AT sfried p1108highcompleteresponseratefollowingpointofcareanticd19cartcelltherapyinpatientswithrelapsedrefractoryfollicularlymphoma AT mjbesser p1108highcompleteresponseratefollowingpointofcareanticd19cartcelltherapyinpatientswithrelapsedrefractoryfollicularlymphoma AT eshkury p1108highcompleteresponseratefollowingpointofcareanticd19cartcelltherapyinpatientswithrelapsedrefractoryfollicularlymphoma AT ryerushalmi p1108highcompleteresponseratefollowingpointofcareanticd19cartcelltherapyinpatientswithrelapsedrefractoryfollicularlymphoma AT nshemtov p1108highcompleteresponseratefollowingpointofcareanticd19cartcelltherapyinpatientswithrelapsedrefractoryfollicularlymphoma AT idanylesko p1108highcompleteresponseratefollowingpointofcareanticd19cartcelltherapyinpatientswithrelapsedrefractoryfollicularlymphoma AT ejacoby p1108highcompleteresponseratefollowingpointofcareanticd19cartcelltherapyinpatientswithrelapsedrefractoryfollicularlymphoma AT oitzhaki p1108highcompleteresponseratefollowingpointofcareanticd19cartcelltherapyinpatientswithrelapsedrefractoryfollicularlymphoma AT rshouval p1108highcompleteresponseratefollowingpointofcareanticd19cartcelltherapyinpatientswithrelapsedrefractoryfollicularlymphoma AT mkedmi p1108highcompleteresponseratefollowingpointofcareanticd19cartcelltherapyinpatientswithrelapsedrefractoryfollicularlymphoma AT ashimoni p1108highcompleteresponseratefollowingpointofcareanticd19cartcelltherapyinpatientswithrelapsedrefractoryfollicularlymphoma AT anagler p1108highcompleteresponseratefollowingpointofcareanticd19cartcelltherapyinpatientswithrelapsedrefractoryfollicularlymphoma AT aavigdor p1108highcompleteresponseratefollowingpointofcareanticd19cartcelltherapyinpatientswithrelapsedrefractoryfollicularlymphoma |